Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.
暂无分享,去创建一个
M. Senni | W. Abhayaratna | J. Butler | M. Lelonek | D. Kitzman | M. Petrie | V. Melenovský | M. Treppendahl | B. Borlaug | D. Møller | J. Ezekowitz | M. Kosiborod | Hiroshi Ito | P. van der Meer | V. Chopra | D. von Lewinski | F. Ahmed | K. Sharma | E. Perna | S. Rasmussen | M. Schou | M. Lindegaard | S. Verma | S. Z. Abildstrom | Sanjiv J. Shah | B. Merkely | Julio Núñez | G. K. Hovingh | Melanie J. Davies | Michael Fu | Dennis Wolf
[1] B. Borlaug,et al. Heart Failure With Preserved Ejection Fraction: JACC Scientific Statement. , 2023, Journal of the American College of Cardiology.
[2] D. Kitzman,et al. Design and Baseline Characteristics of STEP-HFpEF Program Evaluating Semaglutide in Patients With Obesity HFpEF Phenotype. , 2023, JACC. Heart failure.
[3] B. Borlaug,et al. Heart Failure With Preserved Ejection Fraction: A Review. , 2023, JAMA.
[4] Akshay S. Desai,et al. Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection Fraction. , 2022, Journal of the American College of Cardiology.
[5] J. Deanfield,et al. Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses , 2022, Diabetes, obesity & metabolism.
[6] Akshay S. Desai,et al. Dapagliflozin for heart failure according to body mass index: the DELIVER trial , 2022, European heart journal.
[7] M. Jensen,et al. Obesity and heart failure with preserved ejection fraction: new insights and pathophysiologic targets. , 2022, Cardiovascular research.
[8] Sanjiv J. Shah,et al. Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection Fraction: JACC State-of-the-Art Review. , 2021, Journal of the American College of Cardiology.
[9] D. Burkhoff,et al. Obesity, venous capacitance, and venous compliance in heart failure with preserved ejection fraction , 2021, European journal of heart failure.
[10] J. Spertus,et al. Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care: JACC State-of-the-Art Review. , 2020, Journal of the American College of Cardiology.
[11] B. Borlaug. Evaluation and management of heart failure with preserved ejection fraction , 2020, Nature Reviews Cardiology.
[12] Sanjiv J. Shah,et al. Quality of life in heart failure with preserved ejection fraction: importance of obesity, functional capacity, and physical inactivity , 2020, European journal of heart failure.
[13] Sanjiv J. Shah,et al. Adverse Renal Response to Decongestion in the Obese Phenotype of Heart Failure with Preserved Ejection Fraction. , 2020, Journal of cardiac failure.
[14] Sanjiv J. Shah,et al. Characterization of the Obese Phenotype of Heart Failure With Preserved Ejection Fraction: A RELAX Trial Ancillary Study. , 2019, Mayo Clinic proceedings.
[15] B. Nicklas,et al. Pivotal Role of Excess Intra-Abdominal Adipose in the Pathogenesis of Metabolic/Obese HFpEF. , 2018, JACC. Heart failure.
[16] B. Nicklas,et al. Regional Adipose Distribution and its Relationship to Exercise Intolerance in Older Obese Patients Who Have Heart Failure With Preserved Ejection Fraction. , 2018, JACC. Heart failure.
[17] G. Fonarow,et al. Obesity and the Obesity Paradox in Heart Failure. , 2018, Progress in cardiovascular diseases.
[18] Deepak L. Bhatt,et al. Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes. , 2017, Journal of the American College of Cardiology.
[19] W. Kraus,et al. Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial. , 2016, JAMA.
[20] R. McKelvie,et al. 6-min walk test provides prognostic utility comparable to cardiopulmonary exercise testing in ambulatory outpatients with systolic heart failure. , 2012, Journal of the American College of Cardiology.
[21] M. Espeland,et al. Impact of the Look AHEAD Intervention on NT‐pro Brain Natriuretic Peptide in Overweight and Obese Adults With Diabetes , 2012, Obesity.
[22] W. Kraus,et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. , 2009, JAMA.
[23] S. Kritchevsky,et al. Weight change and the conservation of lean mass in old age: the Health, Aging and Body Composition Study. , 2005, The American journal of clinical nutrition.
[24] OUP accepted manuscript , 2022, European Heart Journal.